Stock listing
A3E2FR Stock Price, News, Filings & Events — Avalo Therapeutics, Inc.
Selected listing: A3E2FR · LSX · EUR · DE
This page tracks Avalo Therapeutics, Inc.'s A3E2FR:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3E2FR:LSX. A3E2FR:LSX is the stock-level entry point for investors researching Avalo Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3E2FR:LSX
- Asset type
- Stock
- Market cap
- $864.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Avalo Therapeutics, Inc. A3E2FR:LSX stock context
This page tracks Avalo Therapeutics, Inc.'s A3E2FR:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3E2FR:LSX. A3E2FR:LSX is the stock-level entry point for investors researching Avalo Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Avalo Therapeutics, Inc.
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
August 6, 2026
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
July 22, 2026
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
July 7, 2026
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
June 26, 2026
Avalo Therapeutics Appoints Ron Philip to Board of Directors
June 23, 2026
Avalo Therapeutics, Inc. earnings calls
Avalo Therapeutics, Inc. (AVTX) Q3 2024 Earnings Call
October 30, 2024 · Replay with transcript and chapters
Avalo Therapeutics, Inc. (AVTX) Q2 2024 Earnings Call
July 31, 2024 · Replay with transcript and chapters
Avalo Therapeutics, Inc. (AVTX) Q1 2024 Earnings Call
May 1, 2024 · Replay with transcript and chapters
Avalo Therapeutics, Inc. (AVTX) Q4 2023 Earnings Call
February 28, 2024 · Replay with transcript and chapters
Research Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A3E2FR:LSX.
Avalo Therapeutics, Inc. company profile
View the public company page for Avalo Therapeutics, Inc. on 6ix.
Avalo Therapeutics, Inc. news
Read company news and market updates connected to Avalo Therapeutics, Inc..
Avalo Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Avalo Therapeutics, Inc..
Alternate listings
AVTX:NASDAQ
US · USD
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
C6K0:GETTEX
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
AVTX:BOATS
US · USD
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
A3E2FR:LS
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
C6K0:FWB
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
C6K0:TRADEGATE
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
C6K0:DUS
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
C6K0:MUN
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.
C6K0:SWB
DE · EUR
Alternate listing for Avalo Therapeutics, Inc.; the primary context on this page is A3E2FR:LSX.